BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of visual acuity in eyes with geographic atrophy.One-year study results as well as 18-month extensi…
BARCELONA, Spain — A dome-shaped lens design integrated in a novel ocular surface imaging system provides a complete view of the cornea, conjunctiva, sclera and lid margins, allowing for precise detection of abnormalities.Ordinary slit lamp lenses can …
CHICAGO — In this Healio Video Perspective from the AAO meeting, Vikas Chopra, MD, discusses vitreous management for the anterior segment surgeon.“The reason this is important is because vitreous loss is a very uncommon complication of cataract surgery…
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fellow Stockholders, You hav…
NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses an update on pass-through reimbursement.Hovanesian said a CMS ruling that goes into effect in January 2025 will allow hospital outpatient department …
In this Healio Video Perspective from the Tear Film & Ocular Surface Society meeting, Melissa Toyos, MD, FACS, discusses positive pharmacovigilance data for Lumify for the treatment of ocular redness.Lumify (brimonidine tartrate ophthalmic solution 0.0…